IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

Cancer Immunology, Immunotherapy

Volumn 59, Issue 6, 2010, Pages 805-817

  Benatar, Tania ^a,b   Cao, Ming Y ^a,c   Lee, Yoon ^a   Lightfoot, Jeff ^a   Feng, Ningping ^a   Gu, Xiaoping ^a   Lee, Vivian ^a   Jin, Hongnan ^a   Wang, Ming ^a   Wright, Jim A ^a   Young, Aiping H ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c HEALTH CANADA   (Canada)

Author keywords

Antitumor; B cells; Cancer; Eosinophils; IL 17E

Indexed keywords

CISPLATIN; CYTOKINE; INTERLEUKIN 25; INTERLEUKIN 5; ANTINEOPLASTIC AGENT; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; COLON TUMOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG TUMOR; MELANOMA; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CELL STRAIN HT29; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL NEOPLASM; GENETICS; IMAGE PROCESSING; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; TH2 CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; EOSINOPHILIA; FEMALE; HT29 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-17; INTERLEUKIN-5; MICE; MICE, NUDE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION; TH2 CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953101578     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0802-8     Document Type: Article

References (50)

1. S Aggarwal AL Gurney 2002 IL-17: Prototype member of an emerging cytokine family J Leukoc Biol 71 1 8 1:CAS:528:DC%2BD38Xlt1aluw%3D%3D 11781375
2. SD Hurst T Muchamuel DM Gorman JM Gilbert T Clifford S Kwan S Menon B Seymour C Jackson TT Kung JK Brieland SM Zurawski RW Chapman G Zurawski RL Coffman 2002 New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 J Immunol 169 443 453 1:CAS:528:DC%2BD38XltVKisLY%3D 12077275
3. C Dong 2008 Regulation and pro-inflammatory function of interleukin-17 family cytokines Immunol Rev 226 80 86 10.1111/j.1600-065X.2008.00709.x 1:CAS:528:DC%2BD1MXhsFGls77I 19161417
4. SL Gaffen 2009 Structure and signalling in the IL-17 receptor family Nat Rev Immunol 9 556 567 10.1038/nri2586 1:CAS:528:DC%2BD1MXotVClsbo%3D 19575028
5. JL Barlow AN McKenzie 2009 IL-25: A key requirement for the regulation of type-2 immunity Biofactors 35 178 182 10.1002/biof.24 1:CAS:528: DC%2BD1MXnsVSls74%3D 19449446
6. G Pan D French W Mao M Maruoka P Risser J Lee J Foster S Aggarwal K Nicholes S Guillet P Schow AL Gurney 2001 Forced expression of mouse IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice J Immunol 167 6559 6567 1:CAS:528:DC%2BD3MXovVCiu78%3D 11714825
7. MM Fort J Cheung D Yen J Li SM Zurawski S Lo S Menon T Clifford B Hunte R Lesley T Muchamuel SD Hurst G Zurawski MW Leach DM Gorman DM Rennick 2001 IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo Immunity 15 985 995 10.1016/S1074-7613(01)00243-6 1:CAS:528:DC%2BD38Xhsl2ksA%3D%3D 11754819 (Pubitemid 34075378)
8. K Ikeda H Nakajima K Suzuki S Kagami K Hirose A Suto Y Saito I Iwamoto 2003 Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation Blood 101 3594 3596 10.1182/blood-2002-09-2817 1:CAS:528:DC%2BD3sXjs1aqtro%3D 12511410 (Pubitemid 36857947)
9. AM Owyang C Zaph EH Wilson KJ Guild T McClanahan HR Miller DJ Cua M Goldschmidt CA Hunter RA Kastelein D Artis 2006 Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract J Exp Med 203 843 849 10.1084/jem.20051496 16606667
10. N Feng H Jin M Wang C Du JA Wright AH Young 2003 Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts Cancer Chemother Pharmacol 51 247 255 1:CAS:528:DC%2BD3sXit12mt7s%3D 12655444
11. C Du N Feng H Jin M Wang JA Wright AH Young 2003 Preclinical efficacy of Virulizin in human breast, ovarian and prostate tumor models Anticancer Drugs 14 289 294 10.1097/00001813-200304000-00006 1:CAS:528:DC%2BD3sXisF2itLg%3D 12679733 (Pubitemid 36583814)
12. C Du N Feng H Jin V Lee M Wang JA Wright AH Young 2003 Macrophages play a critical role in the anti-tumor activity of virulizin Int J Oncol 23 1341 1346 1:CAS:528:DC%2BD3sXptFCku7k%3D 14532975
13. MY Cao Y Lee N Feng H Li C Du D Miao J Li V Lee H Jin M Wang X Gu JA Wright AH Young 2005 NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin Cancer Immunol Immunother 54 229 242 10.1007/s00262-004-0582-0 1:CAS:528:DC%2BD2MXjs1agsg%3D%3D 15378281 (Pubitemid 40174241)
14. T Benatar MY Cao Y Lee H Li N Feng X Gu V Lee H Jin M Wang S Der J Lightfoot JA Wright AH Young 2008 Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors Cancer Immunol Immunother 57 1757 1769 10.1007/s00262-008-0502-9 1:CAS:528: DC%2BD1cXhtFCgu7vK 18351336
15. DR Welch JE Bisi BE Miller D Conaway EA Seftor KH Yohem LB Gilmore RE Seftor M Nakajima MJ Hendrix 1991 Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line Int J Cancer 47 227 237 10.1002/ijc.2910470211 1:STN:280:DyaK3M7gslWisg%3D%3D 1671030
16. A Wehrend U Hetzel S Huchzermeyer C Klein H Bostedt 2004 Sirius red is able to selectively stain eosinophil granulocytes in bovine, ovine and equine cervical tissue Anat Histol Embryol 33 180 182 10.1111/j.1439-0264.2004.00532.x 1:STN:280:DC%2BD2c3ks1WktQ%3D%3D 15144288 (Pubitemid 38758998)
17. MY Cao Y Lee NP Feng RA Al-Qawasmeh S Viau XP Gu L Lau H Jin M Wang A Vassilakos JA Wright AH Young 2004 NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo J Pharmacol Exp Ther 308 538 546 10.1124/jpet.103.059618 1:CAS:528: DC%2BD2cXhtlSqtbs%3D 14610220 (Pubitemid 38134215)
18. MR Kim R Manoukian R Yeh SM Silbiger DM Danilenko S Scully J Sun ML DeRose M Stolina D Chang GY Van K Clarkin HQ Nguyen YB Yu S Jing G Senaldi G Elliott ES Medlock 2002 Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production Blood 100 2330 2340 10.1182/blood-2002-01-0012 1:CAS:528:DC%2BD38XnvVGis78%3D 12239140
19. GJ Roboz S Rafii 1999 Interleukin-5 and the regulation of eosinophil production Curr Opin Hematol 6 164 168 10.1097/00062752-199905000-00007 1:STN:280:DyaK1M3ktlehtg%3D%3D 10226737 (Pubitemid 29467540)
20. E Tian JR Sawyer DA Largaespada NA Jenkins NG Copeland JD Shaughnessy Jr 2000 Evi27 encodes a novel membrane protein with homology to the IL17 receptor Oncogene 19 2098 2109 10.1038/sj.onc.1203577 1:CAS:528:DC%2BD3cXjsVymtb8%3D 10815801
21. CM Tato A Laurence JJ O'Shea 2006 Helper T cell differentiation enters a new era: le roi est mort; vive le roi! J Exp Med 203 809 812 10.1084/jem.20060522 1:CAS:528:DC%2BD28Xjsl2isr4%3D 16606679
22. PG Fallon SJ Ballantyne NE Mangan JL Barlow A Dasvarma DR Hewett A McIlgorm HE Jolin AN McKenzie 2006 Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion J Exp Med 203 1105 1116 10.1084/jem.20051615 1:CAS:528:DC%2BD28Xjsl2isb4%3D 16606668
23. C Murdoch M Muthana SB Coffelt CE Lewis 2008 The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 618 631 10.1038/nrc2444 1:CAS:528:DC%2BD1cXovV2lsrY%3D 18633355
24. S Goswami P Angkasekwinai M Shan KJ Greenlee WT Barranco S Polikepahad A Seryshev LZ Song D Redding B Singh S Sur P Woodruff C Dong DB Corry F Kheradmand 2009 Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma Nat Immunol 10 496 503 10.1038/ni.1719 1:CAS:528:DC%2BD1MXjslart7k%3D 19329997
25. R Lotfi JJ Lee MT Lotze 2007 Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors J Immunother 30 16 28 10.1097/01.cji.0000211324.53396.f6 1:CAS:528:DC%2BD2sXjtVCh 17198080 (Pubitemid 46052200)
26. JC Grimaldi NX Yu G Grunig BW Seymour F Cottrez DS Robinson N Hosken WG Ferlin X Wu H Soto A O'Garra MC Howard RL Coffman 1999 Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3) J Leukoc Biol 65 846 853 1:CAS:528:DyaK1MXktVCitrk%3D 10380909
27. J Lee WH Ho M Maruoka RT Corpuz DT Baldwin JS Foster AD Goddard DG Yansura RL Vandlen WI Wood AL Gurney 2001 IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 J Biol Chem 276 1660 1664 10.1074/jbc.M008289200 1:CAS:528:DC%2BD3MXmtV2ksA%3D%3D 11058597 (Pubitemid 32096603)
28. EA Rickel LA Siegel BR Yoon JB Rottman DG Kugler DA Swart PM Anders JE Tocker MR Comeau AL Budelsky 2008 Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities J Immunol 181 4299 4310 1:CAS:528:DC%2BD1cXhtVKntbnM 18768888
29. K Takatsu T Kouro Y Nagai 2009 Interleukin 5 in the link between the innate and acquired immune response Adv Immunol 101 191 236 10.1016/S0065- 2776(08)01006-7 1:CAS:528:DC%2BD1MXpsFGmtbg%3D 19231596
30. L Simson JI Ellyard LA Dent KI Matthaei ME Rothenberg PS Foster MJ Smyth CR Parish 2007 Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance J Immunol 178 4222 4229 1:CAS:528:DC%2BD2sXjt1Wlur4%3D 17371978
31. MJ Fernández-Aceñero M Galindo-Gallego J Sanz A Aljama 2000 Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma Cancer 88 1544 1548 10.1002/(SICI)1097-0142(20000401)88:7<1544:: AID-CNCR7>3.0.CO;2-S 10738211 (Pubitemid 30183138)
32. HJ Nielsen U Hansen IJ Christensen CM Reimert N Brünner F Moesgaard 1999 Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue J Pathol 189 487 495 10.1002/(SICI)1096-9896(199912) 189:4<487::AID-PATH484>3.0.CO;2-I 1:STN:280:DC%2BD3c%2Fps12gsw%3D%3D 10629548
33. S Ishibashi Y Ohashi T Suzuki S Miyazaki T Moriya S Satomi H Sasano 2006 Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma Anticancer Res 26 1419 1424 16619553
34. F Benchetrit A Ciree V Vives G Warnier A Gey C Sautès-Fridman F Fossiez N Haicheur WH Fridman E Tartour 2002 Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism Blood 99 2114 2121 10.1182/blood.V99.6.2114 1:CAS:528:DC%2BD38XitF2nurY%3D 11877287 (Pubitemid 34525496)
35. I Kryczek S Wei W Szeliga L Vatan W Zou 2009 Endogenous IL-17 contributes to reduced tumor growth and metastasis Blood 114 357 359 10.1182/blood-2008-09- 177360 1:CAS:528:DC%2BD1MXovVKlsr0%3D 19289853
36. T Korn E Bettelli M Oukka VK Kuchroo 2009 IL-17 and Th17 Cells Annu Rev Immunol 27 485 517 10.1146/annurev.immunol.021908.132710 1:CAS:528: DC%2BD1MXlsFSltrY%3D 19132915
37. A Cirée L Michel S Camilleri-Bröet F Jean Louis M Oster B Flageul P Senet F Fossiez WH Fridman H Bachelez E Tartour 2004 Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome) Int J Cancer 112 113 120 10.1002/ijc.20373 15305382 (Pubitemid 39249498)
38. I Kryczek S Wei L Zou S Altuwaijri W Szeliga J Kolls A Chang W Zou 2007 Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment J Immunol 178 6730 6733 1:CAS:528: DC%2BD2sXlsVOnt7s%3D 17513719
39. GE Steiner ME Newman D Paikl U Stix N Memaran-Dagda C Lee MJ Marberger 2003 Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate Prostate 56 171 182 10.1002/pros.10238 1:CAS:528:DC%2BD3sXntVWgu7w%3D 12772186 (Pubitemid 36918167)
40. I Kryczek M Banerjee P Cheng L Vatan W Szeliga S Wei E Huang E Finlayson D Simeone TH Welling A Chang G Coukos R Liu W Zou 2009 Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 1141 1149 10.1182/blood-2009-03-208249 1:CAS:528:DC%2BD1MXhtVSgsbbE 19470694
41. P Muranski A Boni PA Antony L Cassard KR Irvine A Kaiser CM Paulos DC Palmer CE Touloukian K Ptak L Gattinoni C Wrzesinski CS Hinrichs KW Kerstann L Feigenbaum CC Chan NP Restifo 2008 Tumor-specific Th17-polarized cells eradicate large established melanoma Blood 112 362 373 10.1182/blood-2007-11-120998 1:CAS:528:DC%2BD1cXos1Cit70%3D 18354038
42. MA Kleinschek AM Owyang B Joyce-Shaikh CL Langrish Y Chen DM Gorman WM Blumenschein T McClanahan F Brombacher SD Hurst RA Kastelein DJ Cua 2007 IL-25 regulates Th17 function in autoimmune inflammation J Exp Med 204 161 170 10.1084/jem.20061738 1:CAS:528:DC%2BD2sXhtFGjt74%3D 17200411 (Pubitemid 46148766)
43. F Balkwill 2009 Tumour necrosis factor and cancer Nat Rev Cancer 9 361 371 10.1038/nrc2628 1:CAS:528:DC%2BD1MXjvF2gtLk%3D 19343034
44. JK Kundu YJ Surh 2008 Inflammation: gearing the journey to cancer Mutat Res 659 15 30 10.1016/j.mrrev.2008.03.002 1:CAS:528:DC%2BD1cXpsVamsro%3D 18485806
45. CK Wong PF Cheung WK Ip CW Lam 2005 Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB Am J Respir Cell Mol Biol 33 186 194 10.1165/rcmb.2005-0034OC 1:CAS:528:DC%2BD2MXnsVeksbk%3D 15860795 (Pubitemid 41473056)
46. Y Maezawa H Nakajima K Suzuki T Tamachi K Ikeda J Inoue Y Saito I Iwamoto 2006 Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling J Immunol 176 1013 1018 1:CAS:528:DC%2BD28Xht1Cntw%3D%3D 16393988
47. A Capobianco AA Manfredi A Monno P Rovere-Querini C Rugarli 2008 Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells J Immunother 31 458 465 10.1097/CJI.0b013e318174a512 18463539
48. Immunodeficient Models Datasheet, Charles River Laboratories ( http://www.criver.com/flex-content-area/documents/rm-rm-d-immunodeficient- models.pdf )
49. I Puxeddu A Alian AM Piliponsky D Ribatti A Panet F Levi-Schaffer 2005 Human peripheral blood eosinophils induce angiogenesis Int J Biochem Cell Biol 37 628 636 10.1016/j.biocel.2004.09.001 1:CAS:528:DC%2BD2cXhtFGiu7vO 15618019 (Pubitemid 40022939)
50. I Puxeddu D Ribatti E Crivellato F Levi-Schaffer 2005 Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases J Allergy Clin Immunol 116 531 536 10.1016/j.jaci.2005.06.007 1:CAS:528:DC%2BD2MXhtVWhtLbN 16159620 (Pubitemid 41267124)